AAL
32
3
ETR
49
-3
CMI
65
-2
MAC
65
-5
CHRW
48
3
BAC
45
-5
QRVO
61
5
PNW
49
3
AMGN
52
-5
VNO
51
-3
AMAT
58
3
DTE
45
-7
CI
50
-3
GD
59
-5
SYF
88
-2
TGT
43
-2
HSIC
40
-4
BF.B
48
-5
EW
38
2
VFC
57
-5
AAL
32
3
ETR
49
-3
CMI
65
-2
MAC
65
-5
CHRW
48
3
BAC
45
-5
QRVO
61
5
PNW
49
3
AMGN
52
-5
VNO
51
-3
AMAT
58
3
DTE
45
-7
CI
50
-3
GD
59
-5
SYF
88
-2
TGT
43
-2
HSIC
40
-4
BF.B
48
-5
EW
38
2
VFC
57
-5
Financhill
Back

Tonix Pharmaceuticals Holding Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
31

TNXP
Tonix Pharmaceuticals Holding

Last Price:
1.25
Seasonality Move:
-20.3%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
31
Tonix Pharmaceuticals Holding (TNXP) is a Sell

Is Tonix Pharmaceuticals Holding a Buy, Sell or Hold?

  • The current Tonix Pharmaceuticals Holding [TNXP] share price is $1.24. The Score for TNXP is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • TNXP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TNXP Stock Price Chart

What is Tonix Pharmaceuticals Holding's stock price today?

  • The Tonix Pharmaceuticals Holding share price today is $1.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TNXP is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

TNXP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.19 Sell
Relative Strength Index (14 RSI): 18.97 Sell
Chaikin Money Flow: -96076 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.59 - 5.51) Sell
Bollinger Bands (100): (3.85 - 10.69) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

TNXP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.21 Buy
20-day SMA: 2.98 Sell
50-day SMA: 4.52 Sell
200-day SMA: 11.88 Sell
8-day EMA: 1.5 Sell
20-day EMA: 2.63 Sell
50-day EMA: 4.49 Sell
200-day EMA: 33.55 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

Tonix Pharmaceuticals Holding Earnings Growth & TNXP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $38.56 per share, an increase next quarter of $0.96 per share, an increase this year of $230.40 per share, and an increase next year of $8.64 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Tonix Pharmaceuticals Holding Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):